Stakeholders & projects
  • Transatlantic task force on urgent antimicrobial resistance (TATFAR)
    WHO calls on all key stakeholders, including policy-makers and planners, the public and patients, practitioners and prescribers, pharmacists and dispensers, and the pharmaceutical industry, to act and take responsibility for combating antimicrobial resistance.


WHO Regional Office for Europe

  • Antimicrobial resistance
    A network run by the European Centre for Disease Prevention and Control for strengthening Europe’s defences against infectious diseases, including antimicrobial resistance.
  • Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR)
    The aim is to set up a network of national surveillance systems in all countries of the Region that are not part of the European Commission surveillance network. Coordinated by the European Centre for Disease Prevention and Control.

European Centre for Disease Prevention and Control (ECDC)

European Commission (EC)

  • DG Health and Food Safety
    Recognizing that antimicrobial resistance is a global human and animal health concern, promotes the responsible, prudent use of antimicrobial agents to preserve their therapeutic efficacy in both animals and humans.
  • DG Research and Innovation
    Supports its 53 Member States to identify, prevent and overcome potential threats to health, such as antimicrobial resistance.

European Food Safety Authority (EFSA)

  • Antimicrobial resistance
    Provides independent scientific support and advice to managers on the risks to human and animal health related to the possible emergence, spread and transfer of antimicrobial resistance in the food chain and in animal populations.

European Medicines Agency (EMA)

  • Antimicrobial resistance
    An agency of the European Union located in London, United Kingdom, established in 1995, responsible for scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union.

Food and Agriculture Organization of the United Nations (FAO)

  • Antimicrobial Resistance
    The FAO calls for “one health” and “food chain” approaches and is addressing antimicrobial resistance as an intersectoral issue. To guard against antimicrobial resistance and as part of overall efforts to reduce hunger, the FAO helps countries to develop and promote measures that help slow down the development and expansion of resistance to essential veterinary drugs.

World Organisation for Animal Health (OIE)

  • Antimicrobial resistance
    Calls for a holistic food chain approach and works with veterinarians, farmers and food safety professionals to support best animal health practices for prudent use of antimicrobial agents.


  • National Food Institute
    Funds several antimicrobial resistance projects and monitors risks for antimicrobial resistance with the support of the European Centre for Disease Prevention and Control and the European Food Safety Authority.
  • APRES (European Commission)
    To provide information and recommendations on appropriate prescribing of antibiotics in primary care.
  • ARPEC (European Commission)
    To build on existing paediatric infectious diseases networks and use established methods and existing prescribing databases to develop a prospective surveillance system to monitor rates of antibiotic prescribing and resistance in European children.
  • COMBACTE (European Commission)
    A public-private partnership working to stimulate antibiotic drug development by pioneering new ways of designing and implementing efficient clinical trials for novel antibiotics.
  • GRACE (European Commission)
    To integrate and coordinate the activities of physicians and scientists in many institutions in 14 European countries to combat antibiotic resistance in community-acquired lower respiratory tract infections.
  • JPIAMR (European Commission)
    To aid implementation of the Joint Programming Initiative on Antimicrobial Resistance, which has 18 participating countries and organizations, eight of which are partners in the consortium.
  • NONANTIRES (European Commission)
    To establish the molecular mechanism of protection and discover new molecules that act as antibiotic adjuvants, ultimately providing better therapeutic solutions for combatting multidrug-resistant microbes.
Related sections
  • Information and evidence resources, issue briefs, case studies and evidence synthesis briefs that can inform policy-making.

    See all
    Evidence and evidence-informed practice
    Databases: 7Overviews: 9
  • A collection of policies and analyses in this area of public health in the WHO European Region.

    See all
    Policy & analysis
    Policy: 13Analysis: 5
  • A reference list of tools and methods to aid in the design, implementation and monitoring of policies in this area of public health.

    See all
    Tools & methods
    Monitoring: 5Policy support: 11
  • Explore related indicators and visualizations, download data in Excel and CSV formats, analyze and share graphics.

    See all
    Indicators & visualizations
    Indicators: 33Visualizations: 68